ProShare Advisors’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $492K | Buy |
43,787
+24,403
| +126% | +$274K | ﹤0.01% | 1140 |
|
|
2025
Q1 | $88.6K | Sell |
19,384
-4,632
| -19% | -$21.2K | ﹤0.01% | 1863 |
|
|
2024
Q4 | $135K | Buy |
24,016
+5,592
| +30% | +$31.5K | ﹤0.01% | 2002 |
|
|
2024
Q3 | $89.2K | Buy |
18,424
+4,417
| +32% | +$21.4K | ﹤0.01% | 1901 |
|
|
2024
Q2 | $68.4K | Sell |
14,007
-3,689
| -21% | -$18K | ﹤0.01% | 1712 |
|
|
2024
Q1 | $235K | Buy |
17,696
+4,184
| +31% | +$55.6K | ﹤0.01% | 1579 |
|
|
2023
Q4 | $188K | Buy |
13,512
+2,755
| +26% | +$38.4K | ﹤0.01% | 1654 |
|
|
2023
Q3 | $143K | Buy |
10,757
+152
| +1% | +$2.02K | ﹤0.01% | 1562 |
|
|
2023
Q2 | $199K | Buy |
+10,605
| New | +$199K | ﹤0.01% | 1547 |
|
|
2023
Q1 | – | Sell |
-11,112
| Closed | -$215K | – | 1912 |
|
|
2022
Q4 | $215K | Buy |
11,112
+1,053
| +10% | +$20.4K | ﹤0.01% | 1451 |
|
|
2022
Q3 | $345K | Buy |
+10,059
| New | +$345K | ﹤0.01% | 1067 |
|
|
2022
Q2 | – | Sell |
-11,817
| Closed | -$270K | – | 2136 |
|
|
2022
Q1 | $270K | Buy |
11,817
+1,595
| +16% | +$36.4K | ﹤0.01% | 1699 |
|
|
2021
Q4 | $377K | Buy |
+10,222
| New | +$377K | ﹤0.01% | 1645 |
|